Document is current
Any future updates will be listed below
-
Authors
Yonesaka, Kimio
Takegawa, Naoki
Watanabe, Satomi
Haratani, Koji
Kawakami, Hisato
Sakai, Kazuko
Chiba, Yasutaka
Maeda, Naoyuki
Kagari, Takashi
Hirotani, Kenji
Nishio, Kazuto
Nakagawa, Kazuhiko
- License Information
-
More Information
Article History
Received: 24 August 2017
Revised: 26 August 2018
Accepted: 4 September 2018
First Online: 9 October 2018
Compliance with ethical standards
:
: Dr. Yonesaka and Dr. Nakagawa received research funding from Daiichi Sankyo Co., Ltd., and Dr. Maeda, Dr. Kagari, and Dr. Hirotani are employees of Daiichi Sankyo Co., Ltd. The remaining authors declare that they have no conflict of interest.
: This study was financially supported by Daiichi Sankyo Co., Ltd. U3-1402 and patritumab were provided by Daiichi Sankyo Co., Ltd.
